Trachoma
31
1
2
21
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
6.5%
2 terminated out of 31 trials
91.3%
+4.8% vs benchmark
65%
20 trials in Phase 3/4
29%
6 of 21 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 21 completed trials
Clinical Trials (31)
RESTORE: Comparing Two Approaches to Repeat TT Surgery Performed by Integrated Eye Care Workers (IECWs)
Azithromycin Reduction to Reach Elimination of Trachoma
Azithromycin Reduction to Reach Elimination of Trachoma B
Sanitation, Water, and Instruction in Face-washing for Trachoma I/II
Kebele Elimination of Trachoma for Ocular Health
Trachoma Elimination Study by Focused Antibiotic (TESFA)
Safety and Immunogenicity of a Chlamydia Vaccine CTH522
Enhancing the A in SAFE for Trachoma
Smartphone App for Taking Images of Conjunctivae
App-based Versus Slide-based Inter-grader Agreement (IGA) Test for Trachoma Graders
Cluster RCT of Co-administration Azithromycin, Albendazole & Ivermectin
Water Uptake for Health in Amhara Pilot
Testing Insect Repellents Against Musca Sorbens, the Vector of Trachoma
Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs )
Tripartite International Research for the Elimination of Trachoma
A Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation: The ASANTE Trial
Partnership for Rapid Elimination of Trachoma
Modified Instrumentation for Surgery to Correct Trichiasis
Performance of a Photoscreener for Vision Screening in a Haitian Pediatric Population
Fluorometholone as Ancillary Therapy for TT Surgery